| Serial Number | 98911999 |
| Word Mark | CO NECTAR |
| Filing Date | Thursday, December 19, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, November 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 15, 2025 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the stylized wording "CO" and "NECTAR" where the letter "O" comprises a circular shape at the center and two additional circular shapes stem off of it extending to the right. Between the letters "O" and "N" are two stacked square shapes. |
| Goods and Services | Pharmaceutical preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; medicines for human purposes, namely, medicinal preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; pharmaceutical preparations for prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; chemical preparations for medical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; biological preparations for medical purposes for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; immunostimulants; radioactive substances for medical purposes; chemico-pharmaceutical preparations; vaccines; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; chemical preparations for pharmaceutical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease |
| Goods and Services | Chemical research; chemical analysis; research and development services in the field of chemistry; biological research; bacteriological research; scientific research in the nature of conducting clinical trials for others; medical research; scientific research in the field of genetics; consulting services in the field of pharmaceutical research and development; research and development of new products for third parties in the scientific and medical field; research and development of new products for others; technological research in the field of pharmaceutical studies; conducting scientific study and research in the fields of medicine, prevention, treatment and management of illness, health care delivery, disease detection and treatment; technical writing; scientific laboratory services; scientific research; technological consultancy in the field of pharmaceuticals; culturing of cells for others for scientific research purposes; laboratory services for biomanufacturing. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 19, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 19, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | HoneyBear Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 115021 TW |
| Party Name | HoneyBear Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 115021 TW |
| Event Date | Event Description |
| Thursday, December 19, 2024 | NEW APPLICATION ENTERED |
| Wednesday, May 28, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 28, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, June 5, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, June 11, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, June 11, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 11, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 11, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, June 11, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 9, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 15, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 15, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, August 14, 2025 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, September 24, 2025 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, November 4, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |